FMSA Holdings (NASDAQ:FMSA) has received a consensus recommendation of “Hold” from the ten brokerages that are currently covering the stock, Analyst Ratings Network.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and five have issued a buy recommendation on the company. On Friday shares of FMSA Holdings Inc (NYSE:FMSA) closed at $6.59. Company’s EPS growth for next 5 years is recorded as 21.00%.
Rite Aid Corporation (NYSE:RAD) announced the opening of its first set of RediClinics, since it acquired the latter in Apr 2014. The launch includes the opening of 24 RediClinics in the greater Baltimore/Washington D.C. and Philadelphia area, within certain Rite Aid pharmacies. Going forward, the company aims to grow this number by opening RediClinics in select pharmacies in its greater Seattle and Texas locations, with openings for the greater Seattle region slated for this spring. Rite Aid Corporation (NYSE:RAD) in last trading activity remains unchanged to close at $7.35. Company weekly performance is 5.30% while its quarterly performance stands at 41.62%. Rite Aid Corporation (NYSE:RAD) is -14.73% away from its 52 week high.
Peabody Energy (NYSE:BTU) announced that it has proactively amended its existing secured credit facility to enhance financial flexibility by modifying the leverage and interest coverage covenants for the life of the facility. Pricing, size and maturity date of the facility remain unchanged. On Friday shares of Peabody Energy Corp. (NYSE:BTU) closed at $7.82. Company’s sales growth for last 5 years was 3.00% and EPS growth for next 5 years is recorded as 12.08%.
Theravance, Inc. (NASDAQ:THRX) announced that on March 19, 2015, the U.S. Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee will discuss the supplemental New Drug Application (NDA) 204275-S001, for fluticasone furoate and vilanterol dry powder for inhalation (with the brand name of BREO ELLIPTA), sponsored by Glaxo Group Limited (d/b/a GSK) for the once-daily treatment for asthma in patients aged 12 years and older. Theravance Inc. (NASDAQ:THRX) in last trading activity moved up 1.12% to close at $12.65. Company weekly performance is 12.24% while its quarterly performance stands at -13.30%. Theravance Inc. (NASDAQ:THRX) is -61.11% away from its 52 week high.
Gildan Activewear Inc. (NYSE:GIL) announced that the nine nominees proposed as directors in its management proxy circular dated December 11, 2014 were elected as directors of the Company by a majority of the votes cast by the shareholders present in person or represented by proxy at its annual meeting of shareholders held on February 5, 2015 in Montréal. Gildan Activewear Inc. (NYSE:GIL) has 5.59% insider ownership while its institutional ownership stands at 83.30%. In last trading activity company’s stock closed at $58.21.